Arformoterol is a long acting beta-adrenoceptor agonist drug indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion under the trade name Brovana as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization.It is the active (RR)-enantiomer of formoterol and was approved by the United States Food and Drug Administration (FDA) on October 6 2006 for the treatment of COPD.
This page contains content from the copyrighted Wikipedia article "Arformoterol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
